XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Feb. 28, 2022
STOCK-BASED COMPENSATION  
Compensation costs related to the Company's stock-based compensation

The following table summarizes the stock-based compensation expense for the three and nine months ended February 28, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

February 28, 

 

 

February 28,  

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

$90

 

 

$14

 

 

$248

 

 

$45

 

Selling, general and administrative

 

 

487

 

 

 

194

 

 

 

1,259

 

 

 

593

 

Research and development

 

 

303

 

 

 

63

 

 

 

679

 

 

 

160

 

Total stock-based compensation

 

$880

 

 

$271

 

 

$2,186

 

 

$798

 

Fair value assumptions for Option Valuation Model

Fair Value. The fair values of the Company’s stock options granted to employees for the three and nine months ended February 28, 2022 and 2021, were estimated using the following weighted average assumptions in the Black-Scholes option valuation model:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

February 28,  

 

 

February 28,

 

 

 

2022

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

5

 

 

 

6

 

 

 

6

 

Volatility

 

 

117%

 

 

77%

 

 

72%

Risk-free interest rate

 

 

1.56%

 

 

1.03%

 

 

0.39%

Weighted average grant date fair value

 

$9.43

 

 

$2.56

 

 

$1.09

 

Fair value assumption of the ESPP Purchase Rights

The fair values of the ESPP purchase rights granted for the nine months ended February 28, 2022 and 2021 were estimated using the following assumptions:

 

 

 

 Nine Months Ended

 

 

 Nine Months Ended

 

 

 

February 28, 2022

 

 

February 28, 2021

 

 

 

 

 

 

 

Expected term (in years)

 

0.5-2.0

 

 

0.5-2.0

 

Volatility

 

 101%-143%

 

 

     74%-82%

 

Risk-free interest rates

 

0.05%-0.27%

 

 

0.10%-0.14%

 

Weighted average grant date fair value

 

$9.57

 

 

$0.44

 

Stock option and RSU transactions

The following tables summarize the Company’s stock option and RSU transactions during the three and nine months ended February 28, 2022 and shows the shares available to be issued at the end of each period (in thousands):

 

 

 

Available

 

 

 

Shares

 

Balance, May 31, 2021

 

 

1,137

 

 

 

 

 

 

Options granted

 

 

(206)

RSUs granted

 

 

(238)

Options cancelled and adjusted

 

 

(8)

 

 

 

 

 

Balance, August 31, 2021

 

 

685

 

 

 

 

 

 

Options reserved                         

 

 

1,414

 

Options granted

 

 

(10)

RSUs granted

 

 

(14)

RSUs performance-based grants

 

 

(270)

Options cancelled

 

 

51

 

 

 

 

 

 

Balance, November 30, 2021

 

 

1,856

 

 

 

 

 

 

Options granted

 

 

(2)

RSUs cancelled

 

 

10

 

Options cancelled

 

 

41

 

 

 

 

 

 

Balance, February 28, 2022

 

 

1,905

 

Stock option transactions

The following table summarizes the stock option transactions during the three and nine months ended February 28, 2022 (in thousands, except per share data):

 

 

 

           Outstanding Options

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Number

 

 

Average

 

 

Aggregate

 

 

 

of

 

 

Exercise

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

Value

 

Balances, May 31, 2021

 

 

2,766

 

 

$2.16

 

 

$807

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

206

 

 

$2.93

 

 

 

 

 

Options cancelled

 

 

(6)

 

$1.95

 

 

 

 

 

Options exercised

 

 

(641)

 

$2.46

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, August 31, 2021

 

 

2,325

 

 

$2.14

 

 

$12,365

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

10

 

 

$19.85

 

 

 

 

 

Options cancelled

 

 

(51)

 

$1.73

 

 

 

 

 

Options exercised

 

 

(571)

 

$2.14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, November 30, 2021

 

 

1,713

 

 

$2.26

 

 

$25,997

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

2

 

 

$11.55

 

 

 

 

 

Options cancelled

 

 

(41)

 

$1.22

 

 

 

 

 

Options exercised

 

 

(66)

 

$2.03

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, February 28, 2022

 

 

1,608

 

 

$2.29

 

 

$18,248

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options fully vested and expected to vest at February 28, 2022

 

 

1,582

 

 

$2.30

 

 

$17,952

 

Options outstanding

The options outstanding and exercisable at February 28, 2022 were in the following exercise price ranges (in thousands, except per share data):

 

 

 

Options Outstanding at February 28, 2022

 

 

Options Exercisable at February 28, 2022

 

Range of Exercise

Prices

 

Number Outstanding Shares

 

 

Weighted Average Remaining Contractual Life (Years)

 

 

Weighted Average Exercise Price

 

 

Number Exercisable Shares

 

 

Weighted Average Remaining Contractual Life (Years)

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value

 

$1.22-$1.34

 

 

51

 

 

 

5.64

 

 

$1.34

 

 

 

51

 

 

 

5.64

 

 

$1.34

 

 

 

 

$1.64-$1.86

 

 

671

 

 

 

4.27

 

 

$1.71

 

 

 

387

 

 

 

3.89

 

 

$1.69

 

 

 

 

$2.03-$2.46

 

 

547

 

 

 

3.13

 

 

$2.23

 

 

 

447

 

 

 

2.92

 

 

$2.23

 

 

 

 

$2.63-$2.93

 

 

223

 

 

 

5.87

 

 

$2.92

 

 

 

47

 

 

 

4.01

 

 

$2.86

 

 

 

 

$3.46-$3.93

 

 

104

 

 

 

2.42

 

 

$3.84

 

 

 

104

 

 

 

2.42

 

 

$3.84

 

 

 

 

$9.94-$19.85

 

 

12

 

 

 

6.69

 

 

$16.54

 

 

 

1

 

 

 

6.65

 

 

$19.46

 

 

 

 

$1.22-$19.85

 

 

1,608

 

 

 

4.04

 

 

$2.29

 

 

 

1,037

 

 

 

3.42

 

 

$2.19

 

 

$11,831